Medical University of South Carolina-Hollings Cancer Center ( Site 0016) is a clinical research site located in Charleston, South Carolina, United States 29425.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Medical University of South Carolina-Hollings Cancer Center ( Site 0016) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Medical University of South Carolina-Hollings Cancer Center ( Site 0016) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Medical University of South Carolina-Hollings Cancer Center ( Site 0016) has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms.
Medical University of South Carolina-Hollings Cancer Center ( Site 0016) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.